Australia markets close in 2 hours 31 minutes

CorMedix Inc. (CRMD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.7600-0.1100 (-2.26%)
At close: 4:00PM EDT
4.7200 -0.04 (-0.84%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.8700
Open4.8800
Bid4.7200 x 900
Ask4.9000 x 800
Day's range4.7200 - 5.0010
52-week range4.3600 - 18.8000
Volume165,526
Avg. volume230,396
Market cap181.291M
Beta (5Y monthly)2.53
PE ratio (TTM)N/A
EPS (TTM)-0.7190
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est21.25
  • GlobeNewswire

    CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

    BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the acceptance for presentation of three abstracts at industry conferences. These include one abstract presented today at the Association of Managed Care Pharmacy (AMCP) Nexus conference in Denver, Colorado, and two abstracts being

  • GlobeNewswire

    CorMedix Inc. Announces Executive Leadership Changes

    BERKELEY HEIGHTS, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced changes to its executive leadership team. Khoso Baluch is retiring from his role as Chief Executive Officer, effective October 4, 2021, and has also resigned from the Company’s Board of Directors. John Armstrong, EVP for Technical O

  • PR Newswire

    Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021

    The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations, today announced that 10 of its member companies will present data from their clinical and research programs at IDWeek 2021 taking place virtually from September 29-October 3, 2021. AWG members are presenting a total of 23 poster presentations and 3 oral abstract presentations.